# Intravenous Lidocaine Plus Intratracheal Dexmedetomidine on Postoperative Sore Throat

> **NCT06952309** · NA · NOT_YET_RECRUITING · sponsor: **Anqing Municipal Hospital** · enrollment: 144 (estimated)

## Conditions studied

- Dexmedetomidine
- Lidocaine
- Sore Throat

## Interventions

- **DRUG:** Intracheal dexmedetomidine
- **DRUG:** Intravenous lidocaine
- **DRUG:** Intravenous lidocaine combined with intracheal dexmedetomidine
- **DRUG:** Saline (NaCl 0,9 %) (placebo)

## Key facts

- **NCT ID:** NCT06952309
- **Lead sponsor:** Anqing Municipal Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-04-25
- **Primary completion:** 2025-09-15
- **Final completion:** 2025-09-25
- **Target enrollment:** 144 (ESTIMATED)
- **Last updated:** 2025-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06952309

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06952309, "Intravenous Lidocaine Plus Intratracheal Dexmedetomidine on Postoperative Sore Throat". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06952309. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*